We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Northrop Grumman Wins $3.2B Deal to Build E-2D Hawkeye Jet
Read MoreHide Full Article
Northrop Grumman Corp.’s (NOC - Free Report) business unit, Aerospace Systems, recently clinched a modification contract for full-rate production of 24 E-2D Advanced Hawkeye aircraft of the 7th lot. The deal was awarded by the Naval Air Systems Command, Patuxent River, Maryland.
Valued at $3.2 billion, this multi-year agreement is expected to be completed by August 2026. Majority of the work related to this deal will be carried out in Melbourne and St. Augustine, FL, as well as Syracuse, NY.
A Brief Note on Hawkeye Aircraft
Hawkeye is an airborne, all-weather, tactical, early-warning aircraft used by the U.S. Navy. E-2D is the fourth version of the E-2 Hawkeye. The technology and gadgets fitted in this aircraft increase its visibility on targets far away. Notably, the E-2D Advanced Hawkeye has a structurally distinctive design — a rotating rotodome and four vertical stabilizer tail configurations — that provides 360-degree surveillance at all times.
Northrop Grumman is supported by other industry leaders on this program. Lockheed Martin’s (LMT - Free Report) unit — Lockheed Martin Naval Electronics and Surveillance Systems — supplies the principal AN/APY-9 radar system for the Hawkeye. L-3 Technologies’ unit supplies the ultra-high frequency electronically scanned array antenna. Meanwhile, Raytheon’s Space and Airborne Systems provides the T-56-A engines.
Northrop Grumman Prospects
In recent times, the importance of military aircraft in the U.S. aerospace-defense market has gained significant traction. This upside can be attributed to advancements and integration of new tactical and logistical features along with the inclusion of improved radar systems and the availability of advanced system engineering services. Being a prominent aircraft manufacturer, Northrop Grumman is benefiting from such crucial developments that are resulting in solid demand for combat jets.
Furthermore, the company’s Aerospace Systems unit develops and designs military aviation aircraft, manned aircraft, autonomous systems and spacecraft. These product lines allow the division to receive a steady inflow of contracts from the Pentagon and the foreign allies of the United States. As a result, this segment has been witnessing solid top-line growth. In the fourth quarter of 2018, the Aerospace Systems unit generated 6% revenue growth, with the Hawkeye jet being one of the contributors to its top-line performance.
As the E-2D Hawkeye Aircraft is a significant defense program for the government of the United States, we can expect more contract inflows like the latest one in the near future. These, in turn, should further bolster the Aerospace segment’s top line in coming days.
Last month, the U.S. government proposed its fiscal 2020 defense budget that includes a spending plan of $57.7 billion on aircraft, a massive increase of 166% from the approved fiscal 2019 defense spending on aircraft. If approved, such spending provision should usher in more contracts for Northrop Grumman moving ahead.
Price Performance
Shares of Northrop Grumman have lost 21.8% in a year compared with the industry’s 3.7% decline.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Northrop Grumman Wins $3.2B Deal to Build E-2D Hawkeye Jet
Northrop Grumman Corp.’s (NOC - Free Report) business unit, Aerospace Systems, recently clinched a modification contract for full-rate production of 24 E-2D Advanced Hawkeye aircraft of the 7th lot. The deal was awarded by the Naval Air Systems Command, Patuxent River, Maryland.
Valued at $3.2 billion, this multi-year agreement is expected to be completed by August 2026. Majority of the work related to this deal will be carried out in Melbourne and St. Augustine, FL, as well as Syracuse, NY.
A Brief Note on Hawkeye Aircraft
Hawkeye is an airborne, all-weather, tactical, early-warning aircraft used by the U.S. Navy. E-2D is the fourth version of the E-2 Hawkeye. The technology and gadgets fitted in this aircraft increase its visibility on targets far away. Notably, the E-2D Advanced Hawkeye has a structurally distinctive design — a rotating rotodome and four vertical stabilizer tail configurations — that provides 360-degree surveillance at all times.
Northrop Grumman is supported by other industry leaders on this program. Lockheed Martin’s (LMT - Free Report) unit — Lockheed Martin Naval Electronics and Surveillance Systems — supplies the principal AN/APY-9 radar system for the Hawkeye. L-3 Technologies’ unit supplies the ultra-high frequency electronically scanned array antenna. Meanwhile, Raytheon’s Space and Airborne Systems provides the T-56-A engines.
Northrop Grumman Prospects
In recent times, the importance of military aircraft in the U.S. aerospace-defense market has gained significant traction. This upside can be attributed to advancements and integration of new tactical and logistical features along with the inclusion of improved radar systems and the availability of advanced system engineering services. Being a prominent aircraft manufacturer, Northrop Grumman is benefiting from such crucial developments that are resulting in solid demand for combat jets.
Furthermore, the company’s Aerospace Systems unit develops and designs military aviation aircraft, manned aircraft, autonomous systems and spacecraft. These product lines allow the division to receive a steady inflow of contracts from the Pentagon and the foreign allies of the United States. As a result, this segment has been witnessing solid top-line growth. In the fourth quarter of 2018, the Aerospace Systems unit generated 6% revenue growth, with the Hawkeye jet being one of the contributors to its top-line performance.
As the E-2D Hawkeye Aircraft is a significant defense program for the government of the United States, we can expect more contract inflows like the latest one in the near future. These, in turn, should further bolster the Aerospace segment’s top line in coming days.
Last month, the U.S. government proposed its fiscal 2020 defense budget that includes a spending plan of $57.7 billion on aircraft, a massive increase of 166% from the approved fiscal 2019 defense spending on aircraft. If approved, such spending provision should usher in more contracts for Northrop Grumman moving ahead.
Price Performance
Shares of Northrop Grumman have lost 21.8% in a year compared with the industry’s 3.7% decline.
Zacks Rank
Northrop Grumman currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>